20.03
0.69 (3.57%)
| Penutupan Terdahulu | 19.34 |
| Buka | 18.88 |
| Jumlah Dagangan | 2,254,713 |
| Purata Dagangan (3B) | 1,617,116 |
| Modal Pasaran | 1,140,084,480 |
| Harga / Jualan (P/S) | 3.23 |
| Harga / Buku (P/B) | 3.05 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2026 |
| Margin Keuntungan | -36.20% |
| Margin Operasi (TTM) | -39.67% |
| EPS Cair (TTM) | -1.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 55.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.02% |
| Nisbah Semasa (MRQ) | 8.95 |
| Aliran Tunai Operasi (OCF TTM) | -83.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -58.77 M |
| Pulangan Atas Aset (ROA TTM) | -13.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | PROCEPT BioRobotics Corporation | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -1.0 |
| Purata | 0.67 |
|
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.22% |
| % Dimiliki oleh Institusi | 93.06% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |